Krishna Institute of Medical Sciences Ltd.

NSE: KIMS | BSE: 543308

Expensive Performer

Download real time

718.00 -1.90 (-0.26%)

High volume today

NSE 27 Oct, 2025 3:31 PM (IST)

28,730

Market Cap

High in industry

0.8

Beta 1Year

Very Low volatility

Krishna Institute of Medical Sciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for KIMS, BSE:543308 Krishna Institute of Medical Sciences Ltd.

Search Inside the pdf :

Krishna Institute of Medical Sciences Ltd.

25 Oct 2025

718.00

-0.26%

Pick of the Week:Krishna Institu.

Buy: Krishna Institute of Medic...

Target

Axis Direct

BUY with a target price of Rs 792, implying an upside of ~10% from the CMP.

Krishna Institute of Medical Sciences Ltd. is trading above its 200 day SMA of 666.0

Krishna Institute of Medical Sciences Ltd.

09 Sep 2025

718.00

-0.26%

KIMS Ltd.

Buy: Krishna Institute of Medic...

ICICI Direct

Well planned expansion based on proven track record incorporated in the year 2000 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The hospital operates in five geographic clusters- i) Andhra Pradesh; ii)...

Krishna Institute of Medical Sciences Ltd. has gained 37.35% in the last 1 Year

Krishna Institute of Medical Sciences Ltd.

01 Sep 2025

718.00

-0.26%

KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED

Accumulate: Krishna Institute of Medic...

Target

Geojit BNP Paribas

*over or under performance to benchmark index In Q1FY25, inpatient volume was up 15.3% YoY and 6.22% QoQ, while outpatient KIMS ramped up its capacity to 5,499 beds in Q1FY26. However, occupancy...

Krishna Institute of Medical Sciences Ltd. is trading below its 30 day SMA of 722.7

Krishna Institute of Medical Sciences Ltd.

08 Aug 2025

718.00

-0.26%

Krishna Institute of Medical Sciences (KIMS IN) Q1FY26 Result...

Buy: Krishna Institute of Medic...

Target

Prabhudas Lilladhar

Krishna Institute of Medical Sciences (KIMS) reported EBITDA growth of 7.4% YoY, below our estimates impacted by higher losses from new units. Our FY26E EBITDA stands reduced by 5%, however FY27E EBITDA broadly remains unchanged as new units are likely to ramp up. The company is on track to commercialize greenfield expansions at Bengaluru markets by Q2FY26. New leadership team hiring across Karnataka and Kerala provides comfort for faster ramp-up in these clusters. Given its lean cost structure and partnership...

Krishna Institute of Medical Sciences Ltd. is trading above its 200 day SMA of 666.0

Krishna Institute of Medical Sciences Ltd.

08 Aug 2025

718.00

-0.26%

Result Update:Krishna Institu.

Buy: Krishna Institute of Medic...

Target

Axis Direct

We maintain our BUY rating on the stock with a target price of Rs 830/share,

Krishna Institute of Medical Sciences Ltd. is trading at high day volume of 1.3M.

Krishna Institute of Medical Sciences Ltd.

30 Jun 2025

718.00

-0.26%

Krishna Institute of Medical Sciences (KIMS IN) Management Meet...

Buy: Krishna Institute of Medic...

Prabhudas Lilladhar

Given its lean cost structure and partnership with local doctors/ leadership outside Andhra Pradesh (AP) and Telangana, the management remains confident of achieving faster breakeven and +25% OPM across Maharashtra,...

Number of FII/FPI investors decreased from 257 to 239 in Sep 2025 qtr

Krishna Institute of Medical Sciences Ltd.

25 Jun 2025

718.00

-0.26%

KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED

Accumulate: Krishna Institute of Medic...

Recommendation Target

Geojit BNP Paribas

KIMS demonstrated strong financial performance, with key parameters such as average revenue per occupied bed (ARPOB) and average revenue per patient (ARPP) growing on a YoY basis. A spate of initiatives, expansions and new equipment were launched during the year. The company is confident about its future prospects and expects to benefit from its commitment to quality services and expertise. With new units poised to contribute to the company's performance, KIMS...

Number of FII/FPI investors decreased from 257 to 239 in Sep 2025 qtr

Krishna Institute of Medical Sciences Ltd.

14 May 2025

718.00

-0.26%

Growth levers across clusters in place; valuation pricey

Hold: Krishna Institute of Medic...

ICICI Securities Limited

Krishna Institute of Medical Sciences’ (KIMS) delivered robust performance in Q4FY25 with revenue/EBITDA/PAT surging 26%/29%/49%, respectively. Existing clusters of AP/ Telangana grew 19%/23% while EBITDA growth was much faster at 37%/34% YoY, respectively.

Krishna Institute of Medical Sciences Ltd. is trading at high day volume of 1.3M.

Krishna Institute of Medical Sciences Ltd.

14 May 2025

718.00

-0.26%

Krishna Institute of Medical Sciences (KIMS IN) Q4FY25 Result...

Buy: Krishna Institute of Medic...

Prabhudas Lilladhar

YoY, adj for one offs; was in line with our estimates. Our FY26E/FY27E EBITDA broadly remain unchanged. The company is on track to commercialize greenfield expansions across Thane and Bengaluru markets by H1FY26. New leadership team hiring across Karnataka and Kerala provides comfort for faster ramp-up in these clusters. Given its lean cost structure and partnership...